BILL · 2009–10 SESSION · LATEST VERSION SHB 1412

HB 1412: Neurodevelopmental therapies

Concerning health benefit plan coverage of neurodevelopmental therapies.

Summary

  • Expands the neurodevelopmental therapy mandate that applies to the Public Employees Benefit Board health programs and group health plans.

From the House Bill Report (HB 1412), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 20, 2009
  2. Out of committeestopped here
  3. Passed House
  4. Passed Senate
  5. Governor
  6. Law
Prime sponsor
Ruth Kagi (D-32)
Introduced
January 20, 2009 in the House
Last action
March 15, 2010
Budget
Has a fiscal note
Versions
HB 1412, SHB 1412

AN ACT Relating to health benefit plan coverage of neurodevelopmental therapies;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. By resolution, reintroduced and retained in present status. (SHB 1412)
  2. By resolution, reintroduced and retained in present status.
  3. By resolution, reintroduced and retained in present status. (SHB 1412)
  4. By resolution, reintroduced and retained in present status.
  5. Committee relieved of further consideration. (SHB 1412)
  6. Referred to Ways & Means. (SHB 1412)
  7. Referred to Ways & Means.
  8. Committee relieved of further consideration.
  9. Referred to Health & Human Services Appropriations. (SHB 1412)
  10. Referred to Health & Human Services Appropriations.
  11. HCW - Majority; 1st substitute bill be substituted, do pass. (SHB 1412)
  12. Minority; do not pass. (SHB 1412)
  13. Minority; do not pass.
  14. HCW - Majority; 1st substitute bill be substituted, do pass.
  15. HCW - Executive action taken by committee.
  16. First reading, referred to Health Care & Wellness.

HB 1412 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page